Mediwhale Secures $12 Million in Series A2 Funding to Drive Global Leadership in Cardiovascular and Metabolic Disease Management ...Middle East

SEOUL, South Korea, Sept. 25, 2024 /PRNewswire/ -- Mediwhale, the AI-powered health diagnostics company, announced $12 million series A2 investments. This funding leverages the momentum of their technological advancements and rapid adoption of its innovative biomarker for preventing...

Hence then, the article about mediwhale secures 12 million in series a2 funding to drive global leadership in cardiovascular and metabolic disease management was published today ( Wednesday 25/09/2024 - 09:05 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mediwhale Secures $12 Million in Series A2 Funding to Drive Global Leadership in Cardiovascular and Metabolic Disease Management )

Also on site :

• General manager position restricted to only Saudis; Qiwa clarifies
• The NFL Names Its First-Ever 'Chief Kindness Officer' Ahead of Super Bowl LX
• Lady Gaga Pauses Tokyo Concert to Condemn ICE and Support Americans ‘Who Are Being Mercilessly Targeted’: ‘We Need to Get Back to a Place of Safety’